๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Some problems related to the design and analysis of clinical trials

โœ Scribed by Ian F. Tannock

Publisher
Elsevier Science
Year
1992
Tongue
English
Weight
904 KB
Volume
22
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

META-ANALYSIS IN THE DESIGN AND MONITORI
META-ANALYSIS IN THE DESIGN AND MONITORING OF CLINICAL TRIALS
โœ REBECCA DERSIMONIAN ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 828 KB

Results from external studies often play an important role in many aspects of a clinical trial. Their incorporation into the decision making process of a trial, however, is rarely conducted in a formal manner. This conference will address what formal role, if any, meta-analytic summaries of external

A Fortran program for the design and ana
A Fortran program for the design and analysis of sequential clinical trials
โœ John Whitehead; Patrick Marek ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 473 KB

Clinical scientists are becoming increasingly aware of the need to monitor clinical trials in progress, and to validate their procedure by the use of a formal sequential design. An interactive program, written in FORTRAN 77 and called "PEST: Planning and Evaluation of Sequential Tests," is introduce

Time for changes in the design, analysis
Time for changes in the design, analysis, and reporting of rheumatoid arthritis clinical trials
โœ David T. Felson; Jennifer J. Anderson; Robert F. Meenan ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 910 KB

The randomized, controlled clinical trial has become the standard approach to evaluating the efficacy of slow-acting drugs in the treatment of rheumatoid arthritis (RA). Such trials, which were used as far back as the 1940s to evaluate antimalarial agents and gold and as recently as 1988 to evaluate

IMPACT Recommendations for Improving the
IMPACT Recommendations for Improving the Design and Analysis of Clinical Trials in Moderate to Severe Traumatic Brain Injury
โœ Andrew I.R. Maas; Ewout W. Steyerberg; Anthony Marmarou; Gillian S. McHugh; Hest ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 83 KB

Clinical trials in traumatic brain injury (TBI) pose complex methodological challenges, largely related to the heterogeneity of the population. The International Mission on Prognosis and Clinical Trial Design in TBI study group has explored approaches for dealing with this heterogeneity with the aim